data_1dsj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dsj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.7 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 N--CA 1.503 2.189 0 CA-C-O 120.473 0.178 . . . . 1.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.462 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 58' ' ' GLU . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 65' ' ' GLN . 2.6 pm0 -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 p30 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.472 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 2.8 pm0 -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.464 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.407 ' N ' HD11 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.472 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.448 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.477 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HA ' HD11 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.444 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' N ' HD11 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.416 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.464 HE21 ' NE2' ' A' ' 66' ' ' GLN . 4.0 pp0? -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.459 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' GLN . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' LEU . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.481 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.049 -0.024 . . . . 1.0 110.974 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' GLU . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.3 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 119.784 -0.151 . . . . 1.0 111.3 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.47 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -74.55 71.57 1.87 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.12 23.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.381 -1.736 . . . . 1.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.63 -15.02 14.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 117.87 0.835 . . . . 1.0 111.974 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 2.0 pm0 -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.7 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.94 -30.83 50.65 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 91.6 mt -76.63 -38.9 53.89 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.265 -1.788 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -65.5 -36.2 83.15 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.004 -1.85 . . . . 1.0 106.004 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.49 -27.26 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 114.584 -2.846 . . . . 1.0 111.024 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 70' ' ' ILE . 11.1 t60 -71.79 -37.83 70.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.799 -1.56 . . . . 1.0 108.061 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 4.2 m-85 -80.56 -46.95 14.9 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 112.931 -1.94 . . . . 1.0 114.082 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -57.32 -40.4 77.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mt -86.36 -57.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.77 55.24 4.19 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.335 -1.506 . . . . 1.0 109.335 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.672 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.836 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -65.22 28.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 115.861 1.8 . . . . 1.0 115.861 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.0 21.51 35.74 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -120.87 38.51 4.03 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 115.185 -0.507 . . . . 1.0 111.074 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.421 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp -89.0 -29.87 19.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.8 mt -77.64 -35.81 52.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.293 -1.321 . . . . 1.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -65.39 -36.21 83.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.26 -27.85 9.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 114.872 -2.731 . . . . 1.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.453 ' N ' HD13 ' A' ' 70' ' ' ILE . 10.5 t-160 -69.18 -38.93 78.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 116.799 -1.961 . . . . 1.0 106.646 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -73.86 -49.18 26.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.456 -2.156 . . . . 1.0 112.815 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -50.64 -36.37 35.12 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.699 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.7 mt -75.74 -20.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.113 -1.035 . . . . 1.0 110.853 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.36 -25.92 1.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.317 . . . . 1.0 109.809 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 O-C-N 117.782 -3.187 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.867 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -92.13 30.86 1.35 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.671 0.748 . . . . 1.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.51 48.87 0.89 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.74 -9.68 2.11 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.453 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 58' ' ' GLU . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' NE2' ' H ' ' A' ' 65' ' ' GLN . 2.6 pm0 -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp -84.77 -26.55 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 96.2 mt -79.62 -36.86 37.34 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.857 -1.065 . . . . 1.0 110.067 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.65 -34.57 78.16 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.427 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.98 -28.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 115.133 -2.627 . . . . 1.0 110.01 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.427 ' N ' HD13 ' A' ' 70' ' ' ILE . 11.7 t-160 -68.59 -39.3 80.99 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 116.485 -2.086 . . . . 1.0 106.956 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.1 m-85 -74.98 -46.72 33.35 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.403 -2.181 . . . . 1.0 113.212 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -53.62 -32.86 52.97 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.89 -0.724 . . . . 1.0 112.459 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mt -79.43 -11.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 121.916 0.865 . . . . 1.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 -68.5 1.43 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 119.752 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.845 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -78.51 52.69 1.2 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -84.54 -38.2 9.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 36.9 p30 145.2 -38.61 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.39 1.076 . . . . 1.0 113.264 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 68' ' ' LEU . 4.2 pp -87.12 -25.85 23.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 97.1 mt -77.59 -36.86 51.53 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.244 -1.344 . . . . 1.0 108.794 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -64.9 -34.5 78.54 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.21 -0.996 . . . . 1.0 108.501 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.01 -29.02 6.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 115.841 -2.344 . . . . 1.0 109.689 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -66.04 -41.28 91.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 116.66 -2.016 . . . . 1.0 106.434 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.3 m-85 -74.45 -48.25 28.62 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 112.434 -2.167 . . . . 1.0 113.022 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -57.98 -38.58 76.35 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.446 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -88.75 -53.58 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 123.748 0.655 . . . . 1.0 110.381 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.86 -57.24 1.0 Allowed Glycine 0 N--CA 1.498 2.802 0 CA-C-O 122.197 0.887 . . . . 1.0 112.494 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.739 0 O-C-N 117.992 -3.064 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 66.33 -66.15 0.18 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 114.397 1.258 . . . . 1.0 114.397 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.29 -18.17 0.16 Allowed Glycine 0 N--CA 1.503 3.126 0 CA-C-N 112.806 -1.997 . . . . 1.0 114.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.89 -15.27 10.66 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 2.8 pm0 -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.95 -24.35 33.03 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.13 -40.49 37.91 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.436 -1.711 . . . . 1.0 108.96 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -64.33 -33.91 76.93 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.36 -29.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 115.248 -2.581 . . . . 1.0 110.441 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.416 ' N ' HD11 ' A' ' 70' ' ' ILE . 23.4 t-160 -68.38 -39.53 81.7 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 116.087 -2.245 . . . . 1.0 105.542 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.17 -57.35 8.75 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 111.838 -2.437 . . . . 1.0 107.5 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -51.38 -42.17 61.2 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.31 -0.956 . . . . 1.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.97 -23.39 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.657 -0.817 . . . . 1.0 110.063 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 48.51 7.06 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.406 -1.078 . . . . 1.0 110.406 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.659 0 O-C-N 119.213 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.81 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.29 38.0 3.33 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.171 0.919 . . . . 1.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.04 47.85 3.21 Favored Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.308 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.08 12.27 34.94 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.407 ' N ' HD11 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.48 -32.37 19.49 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 91.4 mt -74.93 -36.45 62.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.174 -1.375 . . . . 1.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -68.23 -33.35 74.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.265 -1.374 . . . . 1.0 108.89 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -83.89 -30.63 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 115.069 -2.652 . . . . 1.0 109.386 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.449 ' N ' HD13 ' A' ' 70' ' ' ILE . 18.0 t-160 -69.71 -34.85 74.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 116.627 -2.029 . . . . 1.0 106.919 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -76.41 -46.5 26.89 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.487 -1.233 . . . . 1.0 110.361 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.4 ttm-85 -53.49 -41.84 66.67 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.457 -1.297 . . . . 1.0 112.089 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.46 -28.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.56 6.06 31.5 Favored Glycine 0 N--CA 1.503 3.112 0 CA-C-O 122.074 0.819 . . . . 1.0 112.264 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.73 0 O-C-N 118.03 -3.041 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.672 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -74.65 59.2 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.83 17.76 0.05 OUTLIER Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.271 -1.442 . . . . 1.0 115.069 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -84.87 27.22 0.77 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.472 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt -84.93 -34.51 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 62.5 mt -75.56 -36.1 60.48 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.546 -1.661 . . . . 1.0 109.141 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.51 -35.37 80.09 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.445 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.25 -30.48 11.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 114.52 -2.872 . . . . 1.0 109.739 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.445 ' N ' HD11 ' A' ' 70' ' ' ILE . 35.1 t60 -68.19 -38.2 81.75 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 116.691 -2.004 . . . . 1.0 108.285 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.9 m-85 -78.45 -41.91 31.43 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 113.126 -1.852 . . . . 1.0 112.953 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -64.4 -39.39 93.76 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.653 -1.219 . . . . 1.0 108.909 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.0 mt -88.22 -43.64 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.844 -0.742 . . . . 1.0 112.316 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.28 18.98 25.15 Favored Glycine 0 N--CA 1.504 3.179 0 CA-C-O 121.878 0.71 . . . . 1.0 113.264 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.781 0 O-C-N 117.833 -3.157 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.913 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 46.36 59.55 3.77 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.349 1.071 . . . . 1.0 112.147 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.83 25.35 0.15 Allowed Glycine 0 N--CA 1.505 3.277 0 C-N-CA 120.065 -1.064 . . . . 1.0 113.139 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.24 51.66 2.19 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.411 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.448 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.41 -31.84 24.44 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 94.5 mt -75.11 -40.61 59.8 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.032 -1.44 . . . . 1.0 108.329 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.0 -33.28 75.37 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.733 -1.187 . . . . 1.0 108.282 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -85.18 -27.99 6.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 114.578 -2.849 . . . . 1.0 110.549 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -67.51 -41.06 85.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.945 -2.302 . . . . 1.0 106.107 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 8.8 m-85 -73.52 -48.8 30.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 111.881 -2.418 . . . . 1.0 113.458 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -53.31 -39.58 64.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.968 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.11 -42.05 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.086 0.866 . . . . 1.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.17 2.29 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.258 -1.137 . . . . 1.0 110.258 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.828 -2.572 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -78.93 59.77 2.71 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.753 -0.832 . . . . 1.0 108.753 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.02 3.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 116.787 1.475 . . . . 1.0 116.787 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -78.8 -2.77 41.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.414 -1.05 . . . . 1.0 108.249 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.477 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.44 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.5 -36.97 18.68 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 99.1 mt -70.4 -39.7 74.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.924 -1.489 . . . . 1.0 110.087 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.98 -34.45 78.47 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.425 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.74 -26.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 114.642 -2.823 . . . . 1.0 110.752 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' N ' HD13 ' A' ' 70' ' ' ILE . 15.0 t-160 -69.56 -40.06 77.03 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 117.465 -1.694 . . . . 1.0 107.063 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -79.0 -47.68 15.82 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.711 -2.495 . . . . 1.0 115.005 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -51.16 -33.07 25.38 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.914 -0.715 . . . . 1.0 111.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.7 -19.74 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.22 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.67 -29.68 0.68 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.666 0 O-C-N 118.069 -3.018 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.691 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -75.55 60.7 1.24 Allowed 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.877 0.846 . . . . 1.0 111.892 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -58.76 -30.32 65.76 Favored Glycine 0 N--CA 1.501 2.968 0 CA-C-N 115.303 -0.862 . . . . 1.0 114.374 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 8.0 t70 140.37 -64.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HA ' HD11 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.444 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.444 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' N ' HD11 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt -81.03 -27.51 35.77 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 90.9 mt -76.5 -29.37 56.79 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.084 -2.325 . . . . 1.0 106.637 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.28 -41.12 83.63 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.549 -1.648 . . . . 1.0 106.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -21.35 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 113.746 -3.181 . . . . 1.0 111.616 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.406 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 16.0 t-160 -87.46 -6.8 58.25 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.398 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -115.46 -46.61 2.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -52.06 -41.53 62.42 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.662 -0.815 . . . . 1.0 112.098 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -76.03 -10.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.832 0.825 . . . . 1.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.6 -25.49 2.84 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.417 -1.873 . . . . 1.0 108.417 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 O-C-N 119.965 -1.903 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' A ACE . . . . . 0.486 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.212 -0.901 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.24 -20.32 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 118.681 2.845 . . . . 1.0 118.681 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 50' A ACE . . . -133.98 43.0 1.3 Allowed Glycine 0 N--CA 1.502 3.066 0 O-C-N 124.225 0.953 . . . . 1.0 112.689 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -142.15 -34.67 0.45 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.464 HE21 ' NE2' ' A' ' 66' ' ' GLN . 4.0 pp0? -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.02 -37.33 64.38 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 76.2 mt -74.53 -34.62 63.04 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.028 -1.896 . . . . 1.0 108.524 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 5.8 t80 -63.34 -39.42 94.5 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.036 -1.838 . . . . 1.0 106.036 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.417 HD13 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -84.48 -23.64 7.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 114.708 -2.797 . . . . 1.0 113.183 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' N ' HD13 ' A' ' 70' ' ' ILE . 23.6 t-160 -85.53 -23.18 27.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.606 -1.179 . . . . 1.0 112.083 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.514 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.18 -40.24 6.52 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 114.468 -1.242 . . . . 1.0 112.702 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -71.39 -44.95 64.0 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.356 -0.938 . . . . 1.0 109.761 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.6 mt -79.46 -30.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.19 -1.004 . . . . 1.0 109.842 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.61 -85.93 0.72 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.804 0 O-C-N 118.229 -2.924 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 50' A ACE . . . . . 0.434 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.212 -0.897 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 58.09 -5.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.735 2.124 . . . . 1.0 116.735 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 50' A ACE . . . -72.03 36.85 0.64 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 114.617 0.607 . . . . 1.0 114.617 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.96 28.23 1.42 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.459 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.443 ' C ' ' H ' ' A' ' 66' ' ' GLN . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 64' ' ' LEU . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.74 -33.42 60.25 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -76.62 -36.34 57.5 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.534 -2.121 . . . . 1.0 108.685 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.91 -36.26 83.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.474 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.07 -29.66 9.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 114.885 -2.726 . . . . 1.0 110.035 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.474 ' N ' HD11 ' A' ' 70' ' ' ILE . 23.6 t-160 -67.02 -35.52 80.09 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 117.64 -1.624 . . . . 1.0 107.546 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -79.0 -47.16 16.75 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 113.596 -1.638 . . . . 1.0 111.217 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.93 -42.32 48.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.825 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 mt -99.45 -37.83 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 123.853 0.721 . . . . 1.0 112.569 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.47 44.76 1.46 Allowed Glycine 0 N--CA 1.503 3.152 0 CA-C-O 122.129 0.849 . . . . 1.0 112.449 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.66 0 O-C-N 118.551 -2.735 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -75.44 67.08 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.804 0.811 . . . . 1.0 110.082 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 53' ' ' THR . . . 63.35 29.03 73.3 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -81.77 39.41 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 51' ' ' GLY . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.437 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.412 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.65 -27.19 27.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 82.6 mt -76.99 -37.97 54.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.761 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.8 -33.63 76.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -85.01 -29.78 6.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 115.475 -2.49 . . . . 1.0 109.783 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.403 ' N ' HD11 ' A' ' 70' ' ' ILE . 5.3 t60 -66.46 -41.72 88.61 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.152 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.5 m-85 -71.55 -51.13 25.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.436 -2.165 . . . . 1.0 111.413 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -55.07 -39.71 69.53 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.891 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.0 mt -89.0 -13.15 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.95 -0.7 . . . . 1.0 110.399 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 -48.62 3.18 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.204 -1.558 . . . . 1.0 109.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 119.145 -2.385 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.822 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 t80 83.22 100.82 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.558 0 O-C-N 125.334 1.646 . . . . 1.0 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.48 -14.51 11.89 Favored Glycine 0 N--CA 1.501 3.024 0 C-N-CA 120.437 -0.887 . . . . 1.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.27 -13.33 61.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD11 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD11 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.452 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt -78.34 -24.54 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 78.5 mt -78.25 -28.85 47.86 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 112.948 -1.933 . . . . 1.0 106.731 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.88 -41.98 79.02 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.639 -1.245 . . . . 1.0 107.639 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' H ' HD11 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -88.65 -22.24 6.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 113.467 -3.293 . . . . 1.0 111.382 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 5.4 t60 -80.17 -15.44 57.05 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.33 -1.348 . . . . 1.0 107.989 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -105.29 -41.38 5.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.754 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -52.39 -32.67 39.92 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.842 -1.143 . . . . 1.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.1 mt -76.21 -12.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 121.886 0.851 . . . . 1.0 111.655 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -44.79 0.27 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.682 -1.145 . . . . 1.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.663 0 O-C-N 118.245 -2.915 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 46.3 m-85 71.49 -63.2 0.43 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 123.419 1.581 . . . . 1.0 112.593 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.29 -78.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 CA-C-N 110.22 -3.173 . . . . 1.0 109.675 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 26.7 t70 -172.18 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.396 -0.902 . . . . 1.0 110.974 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.404 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.404 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -90.35 -33.64 16.0 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 60.2 mt -74.93 -38.87 61.67 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.529 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.83 -38.07 84.2 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.819 -1.552 . . . . 1.0 107.086 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.54 -24.6 7.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 114.871 -2.732 . . . . 1.0 113.445 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -79.44 -24.66 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.547 -1.261 . . . . 1.0 108.642 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.468 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -93.05 -52.12 4.73 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.926 -1.488 . . . . 1.0 111.108 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -48.73 -41.64 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.261 1.578 . . . . 1.0 115.261 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mt -80.55 -12.75 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 120.036 -0.666 . . . . 1.0 112.327 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.96 54.38 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.013 -1.635 . . . . 1.0 109.013 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.849 0 O-C-N 119.22 -2.341 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.74 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -75.45 56.83 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.427 -0.509 . . . . 1.0 112.226 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.73 31.71 0.02 OUTLIER Glycine 0 N--CA 1.503 3.135 0 C-N-CA 119.274 -1.441 . . . . 1.0 115.945 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.81 27.24 0.65 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.47 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' CG1' ' HA ' ' A' ' 58' ' ' GLU . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.495 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.3 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.48 -23.22 26.04 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 61.6 mt -78.52 -27.24 46.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.81 -42.94 85.29 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -90.42 -20.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 113.782 -3.167 . . . . 1.0 111.839 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 8.0 t60 -84.75 -9.94 57.71 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.197 -1.401 . . . . 1.0 108.687 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -109.96 -48.4 3.21 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -46.08 -35.27 4.78 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.548 1.314 . . . . 1.0 114.548 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.94 -19.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.86 -37.51 4.67 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-O 122.201 0.89 . . . . 1.0 112.369 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.009 -2.465 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.889 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 49.38 23.27 0.83 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.621 2.082 . . . . 1.0 116.621 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.31 15.53 39.31 Favored Glycine 0 N--CA 1.505 3.264 0 C-N-CA 120.109 -1.044 . . . . 1.0 111.935 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.89 39.41 2.14 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' C ' HD13 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.25 -28.42 19.93 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 81.3 mt -77.41 -40.03 44.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.623 -1.172 . . . . 1.0 109.549 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 2.1 t80 -65.01 -32.96 74.95 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.09 -29.16 7.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 114.621 -2.831 . . . . 1.0 110.581 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -68.79 -39.89 79.93 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 116.17 -2.212 . . . . 1.0 107.437 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -76.26 -47.84 22.39 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 111.681 -2.509 . . . . 1.0 113.752 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -57.39 -40.14 77.57 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.345 -0.942 . . . . 1.0 109.975 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.3 mt -78.07 -42.86 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.223 -0.991 . . . . 1.0 109.401 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.39 47.5 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-O 122.558 1.088 . . . . 1.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 O-C-N 118.632 -2.687 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.731 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -78.57 65.78 3.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.277 1.037 . . . . 1.0 108.733 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.35 38.89 0.28 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.373 -1.891 . . . . 1.0 108.373 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -125.77 26.12 6.73 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -0.915 . . . . 1.0 111.3 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.23 -37.51 57.61 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 79.9 mt -73.59 -38.24 65.2 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.537 -1.665 . . . . 1.0 107.464 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.497 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 9.6 t80 -58.64 -41.6 86.39 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.99 -20.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 113.953 -3.099 . . . . 1.0 113.984 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -89.35 -13.92 36.78 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.302 -0.959 . . . . 1.0 109.798 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -113.39 -49.89 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.844 -1.071 . . . . 1.0 112.971 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -62.38 -23.24 66.7 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 117.936 -1.506 . . . . 1.0 111.752 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 mt -88.02 -9.33 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.842 -0.743 . . . . 1.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.42 -37.39 1.75 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.773 0 O-C-N 119.561 -2.14 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 50' A ACE . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -73.36 10.56 0.98 Allowed 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.865 -0.734 . . . . 1.0 112.831 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 50' A ACE . . . -20.66 -79.94 0.01 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 116.948 1.539 . . . . 1.0 116.948 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -168.94 -10.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.454 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp -84.48 -27.58 27.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 92.6 mt -77.03 -38.08 53.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.692 -1.595 . . . . 1.0 108.429 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.43 -36.81 84.98 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.969 -1.092 . . . . 1.0 108.516 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.446 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.52 -29.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 114.781 -2.768 . . . . 1.0 109.92 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.446 ' N ' HD11 ' A' ' 70' ' ' ILE . 8.6 t-160 -76.28 -27.12 56.52 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 115.847 -2.341 . . . . 1.0 109.139 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.5 m-85 -85.31 -44.71 12.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.036 -0.984 . . . . 1.0 110.244 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -56.91 -40.34 76.11 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.213 -1.403 . . . . 1.0 107.213 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.1 mt -90.63 -37.33 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.83 13.38 57.75 Favored Glycine 0 N--CA 1.503 3.103 0 CA-C-O 121.818 0.677 . . . . 1.0 113.298 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.823 0 O-C-N 118.092 -3.005 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.823 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 70.66 -45.88 0.61 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -20.21 -57.03 0.01 OUTLIER Glycine 0 N--CA 1.505 3.261 0 CA-C-N 112.941 -1.936 . . . . 1.0 115.408 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -126.27 29.52 5.79 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.47 ' C ' HD11 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.404 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt -78.11 -32.93 50.77 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 73.2 mt -73.69 -35.88 65.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.468 -1.242 . . . . 1.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.83 -35.17 79.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.48 -29.08 6.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 115.313 -2.555 . . . . 1.0 109.308 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.403 ' N ' HD11 ' A' ' 70' ' ' ILE . 13.7 t-160 -65.1 -40.74 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.994 -1.482 . . . . 1.0 107.006 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.0 m-85 -78.58 -48.17 15.72 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 112.507 -2.133 . . . . 1.0 112.681 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.217 -0.993 . . . . 1.0 110.707 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.2 mt -89.26 -36.12 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.11 -74.34 0.26 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.793 0 O-C-N 118.131 -2.982 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 N--CA 1.503 2.189 0 CA-C-O 120.473 0.178 . . . . 1.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 60' ' ' ILE . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 p30 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 66' ' ' GLN . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 60' ' ' ILE . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 67' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 60' ' ' ILE . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 57' ' ' VAL . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 60' ' ' ILE . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.479 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.049 -0.024 . . . . 1.0 110.974 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 65' ' ' GLN . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' N ' HD23 ' A' ' 64' ' ' LEU . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 63' ' ' ILE . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 60' ' ' ILE . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 119.784 -0.151 . . . . 1.0 111.3 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' VAL . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 60' ' ' ILE . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -74.55 71.57 1.87 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.12 23.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.381 -1.736 . . . . 1.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.63 -15.02 14.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 117.87 0.835 . . . . 1.0 111.974 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.5 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.94 -30.83 50.65 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 91.6 mt -76.63 -38.9 53.89 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.265 -1.788 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -65.5 -36.2 83.15 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.004 -1.85 . . . . 1.0 106.004 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.49 -27.26 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 114.584 -2.846 . . . . 1.0 111.024 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' N ' HD12 ' A' ' 70' ' ' ILE . 54.7 t-80 -71.79 -37.83 70.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.799 -1.56 . . . . 1.0 108.061 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 4.2 m-85 -80.56 -46.95 14.9 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 112.931 -1.94 . . . . 1.0 114.082 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -57.32 -40.4 77.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mt -86.36 -57.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.77 55.24 4.19 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.335 -1.506 . . . . 1.0 109.335 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.672 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.836 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -65.22 28.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 115.861 1.8 . . . . 1.0 115.861 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.0 21.51 35.74 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -120.87 38.51 4.03 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 115.185 -0.507 . . . . 1.0 111.074 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp -89.0 -29.87 19.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.8 mt -77.64 -35.81 52.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.293 -1.321 . . . . 1.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -65.39 -36.21 83.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.26 -27.85 9.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 114.872 -2.731 . . . . 1.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' ILE . 10.5 t-160 -69.18 -38.93 78.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 116.799 -1.961 . . . . 1.0 106.646 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -73.86 -49.18 26.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.456 -2.156 . . . . 1.0 112.815 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -50.64 -36.37 35.12 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.699 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.7 mt -75.74 -20.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.113 -1.035 . . . . 1.0 110.853 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.36 -25.92 1.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.317 . . . . 1.0 109.809 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 O-C-N 117.782 -3.187 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.867 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -92.13 30.86 1.35 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.671 0.748 . . . . 1.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.51 48.87 0.89 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.74 -9.68 2.11 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 60' ' ' ILE . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp -84.77 -26.55 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 96.2 mt -79.62 -36.86 37.34 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.857 -1.065 . . . . 1.0 110.067 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 3.4 t80 -66.65 -34.57 78.16 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.98 -28.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 115.133 -2.627 . . . . 1.0 110.01 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' N ' HD12 ' A' ' 70' ' ' ILE . 11.7 t-160 -68.59 -39.3 80.99 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 116.485 -2.086 . . . . 1.0 106.956 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.1 m-85 -74.98 -46.72 33.35 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.403 -2.181 . . . . 1.0 113.212 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -53.62 -32.86 52.97 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.89 -0.724 . . . . 1.0 112.459 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mt -79.43 -11.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 121.916 0.865 . . . . 1.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 -68.5 1.43 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 119.752 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.845 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -78.51 52.69 1.2 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -84.54 -38.2 9.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 36.9 p30 145.2 -38.61 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.39 1.076 . . . . 1.0 113.264 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 66' ' ' GLN . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.2 pp -87.12 -25.85 23.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 67' ' ' LEU . 97.1 mt -77.59 -36.86 51.53 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.244 -1.344 . . . . 1.0 108.794 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -64.9 -34.5 78.54 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.21 -0.996 . . . . 1.0 108.501 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -85.01 -29.02 6.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 115.841 -2.344 . . . . 1.0 109.689 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' N ' HD12 ' A' ' 70' ' ' ILE . 60.1 t-80 -66.04 -41.28 91.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 116.66 -2.016 . . . . 1.0 106.434 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.3 m-85 -74.45 -48.25 28.62 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 112.434 -2.167 . . . . 1.0 113.022 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -57.98 -38.58 76.35 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.446 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -88.75 -53.58 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 123.748 0.655 . . . . 1.0 110.381 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.86 -57.24 1.0 Allowed Glycine 0 N--CA 1.498 2.802 0 CA-C-O 122.197 0.887 . . . . 1.0 112.494 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.739 0 O-C-N 117.992 -3.064 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 66.33 -66.15 0.18 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 114.397 1.258 . . . . 1.0 114.397 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.29 -18.17 0.16 Allowed Glycine 0 N--CA 1.503 3.126 0 CA-C-N 112.806 -1.997 . . . . 1.0 114.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.89 -15.27 10.66 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 60' ' ' ILE . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.2 tp60 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 67' ' ' LEU . 4.2 pp -82.95 -24.35 33.03 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.13 -40.49 37.91 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.436 -1.711 . . . . 1.0 108.96 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -64.33 -33.91 76.93 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.36 -29.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 115.248 -2.581 . . . . 1.0 110.441 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.462 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.4 t-160 -68.38 -39.53 81.7 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 116.087 -2.245 . . . . 1.0 105.542 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.17 -57.35 8.75 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 111.838 -2.437 . . . . 1.0 107.5 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -51.38 -42.17 61.2 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.31 -0.956 . . . . 1.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.97 -23.39 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.657 -0.817 . . . . 1.0 110.063 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 48.51 7.06 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.406 -1.078 . . . . 1.0 110.406 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.659 0 O-C-N 119.213 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.81 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.29 38.0 3.33 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.171 0.919 . . . . 1.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.04 47.85 3.21 Favored Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.308 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.08 12.27 34.94 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.48 -32.37 19.49 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 91.4 mt -74.93 -36.45 62.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.174 -1.375 . . . . 1.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -68.23 -33.35 74.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.265 -1.374 . . . . 1.0 108.89 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -83.89 -30.63 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 115.069 -2.652 . . . . 1.0 109.386 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.496 ' N ' HD12 ' A' ' 70' ' ' ILE . 18.0 t-160 -69.71 -34.85 74.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 116.627 -2.029 . . . . 1.0 106.919 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.7 m-85 -76.41 -46.5 26.89 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.487 -1.233 . . . . 1.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.4 ttm-85 -53.49 -41.84 66.67 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.457 -1.297 . . . . 1.0 112.089 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.46 -28.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.56 6.06 31.5 Favored Glycine 0 N--CA 1.503 3.112 0 CA-C-O 122.074 0.819 . . . . 1.0 112.264 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.73 0 O-C-N 118.03 -3.041 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.672 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -74.65 59.2 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.83 17.76 0.05 OUTLIER Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.271 -1.442 . . . . 1.0 115.069 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -84.87 27.22 0.77 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt -84.93 -34.51 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 62.5 mt -75.56 -36.1 60.48 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.546 -1.661 . . . . 1.0 109.141 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.51 -35.37 80.09 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.25 -30.48 11.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 114.52 -2.872 . . . . 1.0 109.739 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.484 ' N ' HD12 ' A' ' 70' ' ' ILE . 35.1 t60 -68.19 -38.2 81.75 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 116.691 -2.004 . . . . 1.0 108.285 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.9 m-85 -78.45 -41.91 31.43 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 113.126 -1.852 . . . . 1.0 112.953 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -64.4 -39.39 93.76 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.653 -1.219 . . . . 1.0 108.909 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.0 mt -88.22 -43.64 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.844 -0.742 . . . . 1.0 112.316 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.28 18.98 25.15 Favored Glycine 0 N--CA 1.504 3.179 0 CA-C-O 121.878 0.71 . . . . 1.0 113.264 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.781 0 O-C-N 117.833 -3.157 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.913 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 46.36 59.55 3.77 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.349 1.071 . . . . 1.0 112.147 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.83 25.35 0.15 Allowed Glycine 0 N--CA 1.505 3.277 0 C-N-CA 120.065 -1.064 . . . . 1.0 113.139 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.24 51.66 2.19 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 60' ' ' ILE . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 57' ' ' VAL . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.41 -31.84 24.44 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.11 -40.61 59.8 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.032 -1.44 . . . . 1.0 108.329 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.0 -33.28 75.37 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.733 -1.187 . . . . 1.0 108.282 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -85.18 -27.99 6.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 114.578 -2.849 . . . . 1.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.412 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.0 t-160 -67.51 -41.06 85.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.945 -2.302 . . . . 1.0 106.107 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.52 -48.8 30.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 111.881 -2.418 . . . . 1.0 113.458 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -53.31 -39.58 64.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.968 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.11 -42.05 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.086 0.866 . . . . 1.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.17 2.29 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.258 -1.137 . . . . 1.0 110.258 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.828 -2.572 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -78.93 59.77 2.71 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.753 -0.832 . . . . 1.0 108.753 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.02 3.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 116.787 1.475 . . . . 1.0 116.787 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -78.8 -2.77 41.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.414 -1.05 . . . . 1.0 108.249 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 60' ' ' ILE . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.5 -36.97 18.68 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 99.1 mt -70.4 -39.7 74.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.924 -1.489 . . . . 1.0 110.087 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.98 -34.45 78.47 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.74 -26.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 114.642 -2.823 . . . . 1.0 110.752 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.462 ' N ' HD12 ' A' ' 70' ' ' ILE . 15.0 t-160 -69.56 -40.06 77.03 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 117.465 -1.694 . . . . 1.0 107.063 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -79.0 -47.68 15.82 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.711 -2.495 . . . . 1.0 115.005 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -51.16 -33.07 25.38 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.914 -0.715 . . . . 1.0 111.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.7 -19.74 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.22 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.67 -29.68 0.68 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.666 0 O-C-N 118.069 -3.018 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.691 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -75.55 60.7 1.24 Allowed 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.877 0.846 . . . . 1.0 111.892 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -58.76 -30.32 65.76 Favored Glycine 0 N--CA 1.501 2.968 0 CA-C-N 115.303 -0.862 . . . . 1.0 114.374 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 8.0 t70 140.37 -64.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.479 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt -81.03 -27.51 35.77 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 90.9 mt -76.5 -29.37 56.79 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.084 -2.325 . . . . 1.0 106.637 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.28 -41.12 83.63 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.549 -1.648 . . . . 1.0 106.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -91.35 -21.35 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 113.746 -3.181 . . . . 1.0 111.616 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -87.46 -6.8 58.25 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.398 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -115.46 -46.61 2.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -52.06 -41.53 62.42 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.662 -0.815 . . . . 1.0 112.098 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -76.03 -10.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.832 0.825 . . . . 1.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.6 -25.49 2.84 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.417 -1.873 . . . . 1.0 108.417 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 O-C-N 119.965 -1.903 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 50' A ACE . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.212 -0.901 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.24 -20.32 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 118.681 2.845 . . . . 1.0 118.681 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 50' A ACE . . . -133.98 43.0 1.3 Allowed Glycine 0 N--CA 1.502 3.066 0 O-C-N 124.225 0.953 . . . . 1.0 112.689 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -142.15 -34.67 0.45 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.02 -37.33 64.38 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 76.2 mt -74.53 -34.62 63.04 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.028 -1.896 . . . . 1.0 108.524 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 5.8 t80 -63.34 -39.42 94.5 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.036 -1.838 . . . . 1.0 106.036 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -84.48 -23.64 7.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 114.708 -2.797 . . . . 1.0 113.183 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.6 t-160 -85.53 -23.18 27.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.606 -1.179 . . . . 1.0 112.083 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.18 -40.24 6.52 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 114.468 -1.242 . . . . 1.0 112.702 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -71.39 -44.95 64.0 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.356 -0.938 . . . . 1.0 109.761 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.6 mt -79.46 -30.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.19 -1.004 . . . . 1.0 109.842 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.61 -85.93 0.72 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.804 0 O-C-N 118.229 -2.924 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.897 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 58.09 -5.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.735 2.124 . . . . 1.0 116.735 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.03 36.85 0.64 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 114.617 0.607 . . . . 1.0 114.617 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.96 28.23 1.42 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.74 -33.42 60.25 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 95.0 mt -76.62 -36.34 57.5 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.534 -2.121 . . . . 1.0 108.685 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.91 -36.26 83.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.07 -29.66 9.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 114.885 -2.726 . . . . 1.0 110.035 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.526 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.6 t-160 -67.02 -35.52 80.09 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 117.64 -1.624 . . . . 1.0 107.546 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -79.0 -47.16 16.75 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 113.596 -1.638 . . . . 1.0 111.217 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.93 -42.32 48.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.825 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 mt -99.45 -37.83 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 123.853 0.721 . . . . 1.0 112.569 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.47 44.76 1.46 Allowed Glycine 0 N--CA 1.503 3.152 0 CA-C-O 122.129 0.849 . . . . 1.0 112.449 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.66 0 O-C-N 118.551 -2.735 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -75.44 67.08 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.804 0.811 . . . . 1.0 110.082 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' THR . . . 63.35 29.03 73.3 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -81.77 39.41 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLY . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.65 -27.19 27.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 82.6 mt -76.99 -37.97 54.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.761 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.8 -33.63 76.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -85.01 -29.78 6.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 115.475 -2.49 . . . . 1.0 109.783 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.457 ' N ' HD12 ' A' ' 70' ' ' ILE . 5.3 t60 -66.46 -41.72 88.61 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.152 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.5 m-85 -71.55 -51.13 25.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.436 -2.165 . . . . 1.0 111.413 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -55.07 -39.71 69.53 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.891 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.0 mt -89.0 -13.15 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.95 -0.7 . . . . 1.0 110.399 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 -48.62 3.18 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.204 -1.558 . . . . 1.0 109.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 119.145 -2.385 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.822 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 t80 83.22 100.82 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.558 0 O-C-N 125.334 1.646 . . . . 1.0 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.48 -14.51 11.89 Favored Glycine 0 N--CA 1.501 3.024 0 C-N-CA 120.437 -0.887 . . . . 1.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.27 -13.33 61.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt -78.34 -24.54 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 78.5 mt -78.25 -28.85 47.86 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 112.948 -1.933 . . . . 1.0 106.731 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.88 -41.98 79.02 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.639 -1.245 . . . . 1.0 107.639 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -88.65 -22.24 6.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 113.467 -3.293 . . . . 1.0 111.382 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 5.4 t60 -80.17 -15.44 57.05 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.33 -1.348 . . . . 1.0 107.989 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -105.29 -41.38 5.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.754 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -52.39 -32.67 39.92 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.842 -1.143 . . . . 1.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.1 mt -76.21 -12.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 121.886 0.851 . . . . 1.0 111.655 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -44.79 0.27 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.682 -1.145 . . . . 1.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.663 0 O-C-N 118.245 -2.915 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 46.3 m-85 71.49 -63.2 0.43 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 123.419 1.581 . . . . 1.0 112.593 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.29 -78.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 CA-C-N 110.22 -3.173 . . . . 1.0 109.675 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 26.7 t70 -172.18 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.396 -0.902 . . . . 1.0 110.974 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 65' ' ' GLN . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' N ' HD23 ' A' ' 64' ' ' LEU . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 63' ' ' ILE . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp -90.35 -33.64 16.0 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 60.2 mt -74.93 -38.87 61.67 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.529 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.83 -38.07 84.2 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.819 -1.552 . . . . 1.0 107.086 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -83.54 -24.6 7.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 114.871 -2.732 . . . . 1.0 113.445 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.7 t-160 -79.44 -24.66 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.547 -1.261 . . . . 1.0 108.642 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -93.05 -52.12 4.73 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.926 -1.488 . . . . 1.0 111.108 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -48.73 -41.64 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.261 1.578 . . . . 1.0 115.261 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mt -80.55 -12.75 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 120.036 -0.666 . . . . 1.0 112.327 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.96 54.38 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.013 -1.635 . . . . 1.0 109.013 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.849 0 O-C-N 119.22 -2.341 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.74 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -75.45 56.83 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.427 -0.509 . . . . 1.0 112.226 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 53' ' ' THR . . . 156.73 31.71 0.02 OUTLIER Glycine 0 N--CA 1.503 3.135 0 C-N-CA 119.274 -1.441 . . . . 1.0 115.945 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.81 27.24 0.65 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 51' ' ' GLY . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.6 pp -86.48 -23.22 26.04 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 61.6 mt -78.52 -27.24 46.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.81 -42.94 85.29 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -90.42 -20.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 113.782 -3.167 . . . . 1.0 111.839 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 62.1 t-80 -84.75 -9.94 57.71 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.197 -1.401 . . . . 1.0 108.687 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -109.96 -48.4 3.21 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -46.08 -35.27 4.78 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.548 1.314 . . . . 1.0 114.548 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.94 -19.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.86 -37.51 4.67 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-O 122.201 0.89 . . . . 1.0 112.369 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.009 -2.465 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.889 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 49.38 23.27 0.83 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.621 2.082 . . . . 1.0 116.621 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.31 15.53 39.31 Favored Glycine 0 N--CA 1.505 3.264 0 C-N-CA 120.109 -1.044 . . . . 1.0 111.935 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.89 39.41 2.14 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 60' ' ' ILE . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 1.5 tm0? -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.4 pp -89.25 -28.42 19.93 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 81.3 mt -77.41 -40.03 44.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.623 -1.172 . . . . 1.0 109.549 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 2.1 t80 -65.01 -32.96 74.95 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.09 -29.16 7.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 114.621 -2.831 . . . . 1.0 110.581 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.432 ' N ' HD12 ' A' ' 70' ' ' ILE . 10.1 t-160 -68.79 -39.89 79.93 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 116.17 -2.212 . . . . 1.0 107.437 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -76.26 -47.84 22.39 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 111.681 -2.509 . . . . 1.0 113.752 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -57.39 -40.14 77.57 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.345 -0.942 . . . . 1.0 109.975 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.3 mt -78.07 -42.86 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.223 -0.991 . . . . 1.0 109.401 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.39 47.5 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-O 122.558 1.088 . . . . 1.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 O-C-N 118.632 -2.687 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.731 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -78.57 65.78 3.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.277 1.037 . . . . 1.0 108.733 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.35 38.89 0.28 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.373 -1.891 . . . . 1.0 108.373 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -125.77 26.12 6.73 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -0.915 . . . . 1.0 111.3 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' VAL . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.23 -37.51 57.61 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 79.9 mt -73.59 -38.24 65.2 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.537 -1.665 . . . . 1.0 107.464 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 9.6 t80 -58.64 -41.6 86.39 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.99 -20.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 113.953 -3.099 . . . . 1.0 113.984 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -89.35 -13.92 36.78 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.302 -0.959 . . . . 1.0 109.798 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -113.39 -49.89 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.844 -1.071 . . . . 1.0 112.971 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -62.38 -23.24 66.7 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 117.936 -1.506 . . . . 1.0 111.752 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 mt -88.02 -9.33 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.842 -0.743 . . . . 1.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.42 -37.39 1.75 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.773 0 O-C-N 119.561 -2.14 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -73.36 10.56 0.98 Allowed 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.865 -0.734 . . . . 1.0 112.831 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -20.66 -79.94 0.01 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 116.948 1.539 . . . . 1.0 116.948 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -168.94 -10.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 60' ' ' ILE . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp -84.48 -27.58 27.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 92.6 mt -77.03 -38.08 53.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.692 -1.595 . . . . 1.0 108.429 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.43 -36.81 84.98 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.969 -1.092 . . . . 1.0 108.516 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.52 -29.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 114.781 -2.768 . . . . 1.0 109.92 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.493 ' N ' HD12 ' A' ' 70' ' ' ILE . 0.8 OUTLIER -76.28 -27.12 56.52 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 115.847 -2.341 . . . . 1.0 109.139 -179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.5 m-85 -85.31 -44.71 12.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.036 -0.984 . . . . 1.0 110.244 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -56.91 -40.34 76.11 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.213 -1.403 . . . . 1.0 107.213 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.1 mt -90.63 -37.33 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.83 13.38 57.75 Favored Glycine 0 N--CA 1.503 3.103 0 CA-C-O 121.818 0.677 . . . . 1.0 113.298 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.823 0 O-C-N 118.092 -3.005 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.823 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 70.66 -45.88 0.61 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -20.21 -57.03 0.01 OUTLIER Glycine 0 N--CA 1.505 3.261 0 CA-C-N 112.941 -1.936 . . . . 1.0 115.408 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -126.27 29.52 5.79 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt -78.11 -32.93 50.77 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 73.2 mt -73.69 -35.88 65.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.468 -1.242 . . . . 1.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.83 -35.17 79.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.48 -29.08 6.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 115.313 -2.555 . . . . 1.0 109.308 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' N ' HD12 ' A' ' 70' ' ' ILE . 13.7 t-160 -65.1 -40.74 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.994 -1.482 . . . . 1.0 107.006 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.0 m-85 -78.58 -48.17 15.72 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 112.507 -2.133 . . . . 1.0 112.681 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.217 -0.993 . . . . 1.0 110.707 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.2 mt -89.26 -36.12 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.11 -74.34 0.26 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.793 0 O-C-N 118.131 -2.982 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 111.974 0.361 . . . . 1.0 111.974 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 2.0 pm0 -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.7 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 N--CA 1.503 2.189 0 CA-C-O 120.473 0.178 . . . . 1.0 111.074 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 60' ' ' ILE . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 2.6 pm0 -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.9 p30 . . . . . 0 N--CA 1.507 2.397 0 N-CA-C 113.264 0.839 . . . . 1.0 113.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 66' ' ' GLN . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 60' ' ' ILE . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.445 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 2.8 pm0 -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 67' ' ' LEU . 4.2 pp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 60' ' ' ILE . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 57' ' ' VAL . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.492 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 . . . . . 0 N--CA 1.494 1.738 0 N-CA-C 108.249 -1.019 . . . . 1.0 108.249 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 60' ' ' ILE . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 . . . . . 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.502 HE21 ' NE2' ' A' ' 66' ' ' GLN . 4.0 pp0? -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.502 ' NE2' HE21 ' A' ' 65' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.049 -0.024 . . . . 1.0 110.974 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 65' ' ' GLN . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' N ' HD23 ' A' ' 64' ' ' LEU . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 63' ' ' ILE . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.3 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 . . . . . 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 60' ' ' ILE . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 119.784 -0.151 . . . . 1.0 111.3 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' VAL . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 60' ' ' ILE . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp . . . . . 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 . . . . . 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.503 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -74.55 71.57 1.87 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.12 23.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.263 0 CA-C-N 113.381 -1.736 . . . . 1.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.63 -15.02 14.51 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 117.87 0.835 . . . . 1.0 111.974 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 t -71.44 -8.4 53.6 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.851 -1.14 . . . . 1.0 110.487 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -63.53 -18.49 63.89 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.394 -1.73 . . . . 1.0 109.139 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.14 -28.7 68.11 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 118.367 -1.333 . . . . 1.0 109.039 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.46 -51.44 12.6 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 105.771 -2.932 . . . . 1.0 105.771 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.7 t -50.65 -47.44 28.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 122.602 1.192 . . . . 1.0 109.783 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -56.34 -27.9 57.33 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.741 -1.572 . . . . 1.0 111.654 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.87 -27.98 62.23 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 118.237 -1.385 . . . . 1.0 109.429 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -79.12 -53.41 13.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 114.0 -1.455 . . . . 1.0 109.116 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.524 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -56.84 -39.76 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.28 -1.378 . . . . 1.0 107.28 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' N ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -48.35 -28.41 3.16 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.676 1.235 . . . . 1.0 113.105 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.7 tt -123.85 10.72 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 CA-C-O 121.433 0.635 . . . . 1.0 111.528 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -76.44 -104.92 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.983 -1.117 . . . . 1.0 107.983 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 2.0 pm0 -59.18 4.01 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 115.871 1.804 . . . . 1.0 115.871 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.7 mp0 -72.73 -37.19 67.82 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.98 -1.859 . . . . 1.0 105.98 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.5 mt -77.94 -30.83 50.65 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 113.487 -1.688 . . . . 1.0 110.418 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 91.6 mt -76.63 -38.9 53.89 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 113.265 -1.788 . . . . 1.0 110.006 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -65.5 -36.2 83.15 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.004 -1.85 . . . . 1.0 106.004 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.49 -27.26 10.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 114.584 -2.846 . . . . 1.0 111.024 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' N ' HD12 ' A' ' 70' ' ' ILE . 11.1 t60 -71.79 -37.83 70.37 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 117.799 -1.56 . . . . 1.0 108.061 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 4.2 m-85 -80.56 -46.95 14.9 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-N 112.931 -1.94 . . . . 1.0 114.082 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -57.32 -40.4 77.85 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.0 mt -86.36 -57.67 4.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.77 55.24 4.19 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.335 -1.506 . . . . 1.0 109.335 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.672 0 O-C-N 118.714 -2.639 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.836 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -65.22 28.12 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 115.861 1.8 . . . . 1.0 115.861 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.0 21.51 35.74 Favored Glycine 0 N--CA 1.503 3.114 0 N-CA-C 109.704 -1.358 . . . . 1.0 109.704 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -120.87 38.51 4.03 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 115.185 -0.507 . . . . 1.0 111.074 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.2 p -90.18 -49.85 6.33 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 125.524 2.583 . . . . 1.0 114.101 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -52.5 -15.62 0.71 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 108.566 -3.925 . . . . 1.0 114.299 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.7 75.98 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.136 -1.026 . . . . 1.0 108.345 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.35 -46.41 41.77 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 105.357 -3.097 . . . . 1.0 105.357 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.5 t -51.66 -50.51 30.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 113.906 -1.147 . . . . 1.0 109.39 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 61' ' ' ILE . 5.8 mt-10 -60.23 -21.69 62.14 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 117.873 -1.531 . . . . 1.0 113.492 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.18 -26.88 68.35 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.07 -1.452 . . . . 1.0 107.174 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.3 mt -78.53 -54.31 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 113.664 -1.607 . . . . 1.0 109.02 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.511 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.5 -36.1 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.082 -1.047 . . . . 1.0 108.769 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -61.29 -16.61 47.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.455 -1.298 . . . . 1.0 112.517 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 tt -114.6 -24.12 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.06 0.933 . . . . 1.0 109.63 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 26.4 tp -51.6 -79.59 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.737 1.615 . . . . 1.0 110.079 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -74.34 -2.09 23.69 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 115.751 -2.38 . . . . 1.0 110.408 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.55 -30.87 41.87 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 116.806 -1.957 . . . . 1.0 108.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.2 pp -89.0 -29.87 19.16 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 123.207 1.479 . . . . 1.0 107.748 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.8 mt -77.64 -35.81 52.17 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.293 -1.321 . . . . 1.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -65.39 -36.21 83.28 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.136 -1.061 . . . . 1.0 108.136 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.26 -27.85 9.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 114.872 -2.731 . . . . 1.0 110.378 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.494 ' N ' HD12 ' A' ' 70' ' ' ILE . 10.5 t-160 -69.18 -38.93 78.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 116.799 -1.961 . . . . 1.0 106.646 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -73.86 -49.18 26.23 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 112.456 -2.156 . . . . 1.0 112.815 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -50.64 -36.37 35.12 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.699 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.7 mt -75.74 -20.31 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.113 -1.035 . . . . 1.0 110.853 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.36 -25.92 1.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.809 -1.317 . . . . 1.0 109.809 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.635 0 O-C-N 117.782 -3.187 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.867 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -92.13 30.86 1.35 Allowed 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.671 0.748 . . . . 1.0 110.21 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.51 48.87 0.89 Allowed Glycine 0 N--CA 1.502 3.048 0 N-CA-C 109.057 -1.617 . . . . 1.0 109.057 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -135.74 -9.68 2.11 Favored 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 113.358 0.873 . . . . 1.0 113.358 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 p -58.22 -31.97 67.86 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 124.93 2.3 . . . . 1.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -56.24 -22.34 29.16 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 108.528 -3.942 . . . . 1.0 112.93 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.1 -32.44 73.89 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.197 -1.409 . . . . 1.0 107.197 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.57 -49.27 19.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 104.759 -3.336 . . . . 1.0 104.759 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.454 ' HA ' HD12 ' A' ' 60' ' ' ILE . 92.0 t -50.7 -48.91 27.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.306 -0.947 . . . . 1.0 110.771 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 3.6 mt-10 -61.04 -23.49 65.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 116.543 -2.063 . . . . 1.0 112.239 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.91 -20.33 65.08 Favored 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 118.763 -1.175 . . . . 1.0 109.376 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.454 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.9 mt -86.44 -54.09 8.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 113.667 -1.606 . . . . 1.0 107.819 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.3 -26.76 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 N-CA-C 107.468 -1.308 . . . . 1.0 107.468 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -51.56 -34.37 36.51 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 124.21 0.944 . . . . 1.0 108.975 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.452 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 9.5 tt -126.18 -2.96 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.416 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . 44.7 tp -47.76 -79.97 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 114.057 -1.428 . . . . 1.0 112.991 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 2.6 pm0 -80.47 1.94 27.24 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 117.215 -1.794 . . . . 1.0 109.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.474 ' OE1' ' N ' ' A' ' 66' ' ' GLN . 20.8 mp0 -78.2 -35.97 47.86 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.398 -1.321 . . . . 1.0 107.494 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp -84.77 -26.55 27.49 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.443 -1.303 . . . . 1.0 108.372 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 96.2 mt -79.62 -36.86 37.34 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.857 -1.065 . . . . 1.0 110.067 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 3.4 t80 -66.65 -34.57 78.16 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.758 -1.201 . . . . 1.0 107.758 -179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.98 -28.93 8.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 115.133 -2.627 . . . . 1.0 110.01 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' N ' HD12 ' A' ' 70' ' ' ILE . 11.7 t-160 -68.59 -39.3 80.99 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 116.485 -2.086 . . . . 1.0 106.956 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.1 m-85 -74.98 -46.72 33.35 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 112.403 -2.181 . . . . 1.0 113.212 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.4 ttp85 -53.62 -32.86 52.97 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.89 -0.724 . . . . 1.0 112.459 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mt -79.43 -11.63 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-O 121.916 0.865 . . . . 1.0 110.833 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.32 -68.5 1.43 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.368 -1.493 . . . . 1.0 109.368 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.649 0 O-C-N 119.752 -2.028 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.845 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -78.51 52.69 1.2 Allowed 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.843 -0.799 . . . . 1.0 108.843 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -84.54 -38.2 9.96 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 36.9 p30 145.2 -38.61 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 124.39 1.076 . . . . 1.0 113.264 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.2 t -90.35 -16.24 29.56 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.127 1.899 . . . . 1.0 116.127 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -63.87 -22.7 67.04 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 112.859 -1.973 . . . . 1.0 111.942 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.6 -25.98 54.39 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.846 -1.142 . . . . 1.0 108.008 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.55 -52.49 12.48 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 106.238 -2.745 . . . . 1.0 106.238 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.0 t -51.54 -45.76 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-O 122.522 1.153 . . . . 1.0 108.574 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.8 OUTLIER -59.21 -27.69 65.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 114.147 -1.388 . . . . 1.0 111.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.85 -15.57 62.64 Favored 'General case' 0 N--CA 1.499 2.02 0 C-N-CA 118.203 -1.399 . . . . 1.0 109.333 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.3 mt -90.11 -57.18 4.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -55.43 -33.98 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 C-N-CA 119.178 -1.009 . . . . 1.0 108.728 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -52.09 -25.12 8.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 124.339 1.024 . . . . 1.0 112.642 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB3' ' A' ' 66' ' ' GLN . 6.5 tt -126.71 -34.66 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 114.694 1.368 . . . . 1.0 114.694 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 31.2 tp -48.67 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.787 1.635 . . . . 1.0 109.582 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 17.2 pt20 -74.91 -0.41 18.49 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 116.111 -2.236 . . . . 1.0 109.497 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 63' ' ' ILE . 3.0 tp-100 -75.58 -35.61 60.54 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.224 -1.398 . . . . 1.0 107.224 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.2 pp -87.12 -25.85 23.92 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.718 1.247 . . . . 1.0 108.325 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 67' ' ' LEU . 97.1 mt -77.59 -36.86 51.53 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.244 -1.344 . . . . 1.0 108.794 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -64.9 -34.5 78.54 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.21 -0.996 . . . . 1.0 108.501 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -85.01 -29.02 6.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 115.841 -2.344 . . . . 1.0 109.689 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' N ' HD12 ' A' ' 70' ' ' ILE . 9.8 t60 -66.04 -41.28 91.1 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 116.66 -2.016 . . . . 1.0 106.434 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.3 m-85 -74.45 -48.25 28.62 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 112.434 -2.167 . . . . 1.0 113.022 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -57.98 -38.58 76.35 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.535 -0.866 . . . . 1.0 110.446 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mt -88.75 -53.58 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 123.748 0.655 . . . . 1.0 110.381 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 70.86 -57.24 1.0 Allowed Glycine 0 N--CA 1.498 2.802 0 CA-C-O 122.197 0.887 . . . . 1.0 112.494 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.739 0 O-C-N 117.992 -3.064 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.816 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 66.33 -66.15 0.18 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 114.397 1.258 . . . . 1.0 114.397 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -45.29 -18.17 0.16 Allowed Glycine 0 N--CA 1.503 3.126 0 CA-C-N 112.806 -1.997 . . . . 1.0 114.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -116.89 -15.27 10.66 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.438 0.637 . . . . 1.0 111.219 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 m -61.07 -20.89 63.11 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 123.407 1.575 . . . . 1.0 110.05 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -60.55 -21.76 62.9 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 110.907 -2.86 . . . . 1.0 111.254 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.45 -27.97 69.48 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 118.767 -1.173 . . . . 1.0 108.277 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.92 -50.55 10.7 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 104.714 -3.354 . . . . 1.0 104.714 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.421 ' HA ' HD12 ' A' ' 60' ' ' ILE . 90.0 t -50.07 -47.22 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 CA-C-O 121.818 0.818 . . . . 1.0 109.912 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 29.9 mm-40 -56.45 -27.8 57.79 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.872 -1.058 . . . . 1.0 111.762 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.57 -18.61 60.55 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.611 -1.235 . . . . 1.0 110.359 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.6 mt -88.23 -53.64 9.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 114.313 -1.312 . . . . 1.0 107.498 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.53 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -56.93 -39.1 63.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -48.41 -28.66 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.491 -0.884 . . . . 1.0 112.351 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.5 -34.32 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.304 0.853 . . . . 1.0 113.304 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 41.4 tp -38.26 -89.76 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 126.407 1.883 . . . . 1.0 111.367 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.445 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 2.8 pm0 -78.44 7.73 6.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 116.646 -2.022 . . . . 1.0 108.237 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -75.24 -36.97 61.24 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.406 -1.717 . . . . 1.0 107.226 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 67' ' ' LEU . 4.2 pp -82.95 -24.35 33.03 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 123.395 1.569 . . . . 1.0 109.011 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.13 -40.49 37.91 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 113.436 -1.711 . . . . 1.0 108.96 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -64.33 -33.91 76.93 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 108.546 -0.909 . . . . 1.0 108.546 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.36 -29.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 C-N-CA 115.248 -2.581 . . . . 1.0 110.441 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.462 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.4 t-160 -68.38 -39.53 81.7 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 116.087 -2.245 . . . . 1.0 105.542 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -65.17 -57.35 8.75 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 111.838 -2.437 . . . . 1.0 107.5 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -51.38 -42.17 61.2 Favored 'General case' 0 N--CA 1.505 2.28 0 C-N-CA 119.31 -0.956 . . . . 1.0 112.502 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.97 -23.39 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 C-N-CA 119.657 -0.817 . . . . 1.0 110.063 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.82 48.51 7.06 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.406 -1.078 . . . . 1.0 110.406 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.659 0 O-C-N 119.213 -2.345 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.81 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -133.29 38.0 3.33 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 124.171 0.919 . . . . 1.0 110.508 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.04 47.85 3.21 Favored Glycine 0 N--CA 1.502 3.078 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.308 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -98.08 12.27 34.94 Favored 'General case' 0 N--CA 1.504 2.264 0 CA-C-O 121.237 0.541 . . . . 1.0 111.344 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.3 p -60.0 -32.3 70.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 124.55 2.119 . . . . 1.0 110.402 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -56.1 -21.29 21.33 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 109.094 -3.685 . . . . 1.0 113.06 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.65 -28.98 69.77 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 118.588 -1.245 . . . . 1.0 108.712 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.29 -49.57 15.14 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 105.346 -3.102 . . . . 1.0 105.346 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 87.4 t -50.73 -48.02 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-N 114.724 -0.738 . . . . 1.0 109.374 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.41 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.4 mm-40 -57.24 -22.81 43.81 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-N 115.383 -0.826 . . . . 1.0 111.904 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.82 -14.95 53.41 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 118.762 -1.175 . . . . 1.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -90.21 -54.33 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.655 -1.609 . . . . 1.0 106.655 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.6 pp -55.01 -43.67 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-N 114.199 -1.364 . . . . 1.0 109.228 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' N ' HD12 ' A' ' 61' ' ' ILE . 60.8 mtm180 -56.92 -20.66 24.64 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.99 -1.484 . . . . 1.0 114.275 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mp -112.99 -21.05 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 CA-C-O 121.714 0.769 . . . . 1.0 111.625 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 31.4 tp -55.3 -96.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 123.031 1.396 . . . . 1.0 109.992 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 7.3 pt20 -69.72 3.87 2.26 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 119.182 -1.007 . . . . 1.0 111.128 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -33.77 50.51 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 116.873 -1.931 . . . . 1.0 107.832 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.4 mt -87.48 -32.37 19.49 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.063 -1.426 . . . . 1.0 108.502 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 91.4 mt -74.93 -36.45 62.14 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.174 -1.375 . . . . 1.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -68.23 -33.35 74.24 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.265 -1.374 . . . . 1.0 108.89 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -83.89 -30.63 7.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 115.069 -2.652 . . . . 1.0 109.386 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.496 ' N ' HD12 ' A' ' 70' ' ' ILE . 18.0 t-160 -69.71 -34.85 74.45 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 116.627 -2.029 . . . . 1.0 106.919 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.7 m-85 -76.41 -46.5 26.89 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.487 -1.233 . . . . 1.0 110.361 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.4 ttm-85 -53.49 -41.84 66.67 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.457 -1.297 . . . . 1.0 112.089 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.4 mt -102.46 -28.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 113.906 1.076 . . . . 1.0 113.906 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.56 6.06 31.5 Favored Glycine 0 N--CA 1.503 3.112 0 CA-C-O 122.074 0.819 . . . . 1.0 112.264 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.73 0 O-C-N 118.03 -3.041 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.672 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -74.65 59.2 0.84 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 112.69 0.626 . . . . 1.0 112.69 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.83 17.76 0.05 OUTLIER Glycine 0 N--CA 1.503 3.106 0 C-N-CA 119.271 -1.442 . . . . 1.0 115.069 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -84.87 27.22 0.77 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.45 -25.34 67.96 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 124.506 2.098 . . . . 1.0 110.589 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.42 -20.46 59.84 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 110.175 -3.193 . . . . 1.0 112.901 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.91 -27.12 68.93 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.326 -1.35 . . . . 1.0 108.427 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.46 -50.25 21.7 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 105.461 -3.056 . . . . 1.0 105.461 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -51.31 -51.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 CA-C-N 114.232 -0.984 . . . . 1.0 109.461 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.451 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 6.9 mm-40 -56.74 -23.8 45.31 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.163 -1.015 . . . . 1.0 112.364 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.02 -24.66 59.6 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.091 -1.443 . . . . 1.0 109.007 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.2 mt -81.35 -52.24 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 114.078 -1.419 . . . . 1.0 108.07 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -60.25 -33.06 52.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 106.17 -1.789 . . . . 1.0 106.17 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -29.5 2.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.031 0.832 . . . . 1.0 111.585 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 5.1 tt -119.2 -26.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 123.87 0.731 . . . . 1.0 112.768 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.42 -73.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.357 0.599 . . . . 1.0 109.531 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 61' ' ' ILE . 9.4 mp0 -65.19 -8.56 17.81 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 116.801 -1.96 . . . . 1.0 112.122 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -82.71 -27.65 31.04 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 115.206 -2.598 . . . . 1.0 107.746 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 96.0 mt -84.93 -34.51 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.887 1.327 . . . . 1.0 107.665 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 62.5 mt -75.56 -36.1 60.48 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.546 -1.661 . . . . 1.0 109.141 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -66.51 -35.37 80.09 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.483 -1.303 . . . . 1.0 107.483 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.25 -30.48 11.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 114.52 -2.872 . . . . 1.0 109.739 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.484 ' N ' HD12 ' A' ' 70' ' ' ILE . 35.1 t60 -68.19 -38.2 81.75 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 116.691 -2.004 . . . . 1.0 108.285 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.9 m-85 -78.45 -41.91 31.43 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 113.126 -1.852 . . . . 1.0 112.953 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -64.4 -39.39 93.76 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.653 -1.219 . . . . 1.0 108.909 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.0 mt -88.22 -43.64 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.844 -0.742 . . . . 1.0 112.316 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.28 18.98 25.15 Favored Glycine 0 N--CA 1.504 3.179 0 CA-C-O 121.878 0.71 . . . . 1.0 113.264 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.781 0 O-C-N 117.833 -3.157 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.913 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 46.36 59.55 3.77 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 122.349 1.071 . . . . 1.0 112.147 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.83 25.35 0.15 Allowed Glycine 0 N--CA 1.505 3.277 0 C-N-CA 120.065 -1.064 . . . . 1.0 113.139 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -89.24 51.66 2.19 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 106.488 -1.671 . . . . 1.0 106.488 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.7 p -81.47 -35.99 29.85 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 124.479 2.085 . . . . 1.0 113.499 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -52.1 -18.99 1.66 Allowed 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 110.043 -3.253 . . . . 1.0 115.462 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.69 71.72 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.092 -1.077 . . . . 1.0 108.092 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.19 -51.52 27.31 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 105.562 -3.015 . . . . 1.0 105.562 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' HD12 ' A' ' 60' ' ' ILE . 74.6 t -49.48 -53.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.28 -0.96 . . . . 1.0 108.758 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.408 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -53.8 -27.02 26.67 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.624 179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.89 -25.44 62.79 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 118.394 -1.322 . . . . 1.0 109.34 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 57' ' ' VAL . 6.3 mt -81.74 -51.58 14.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.509 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.492 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.3 pp -61.83 -34.18 61.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.599 -1.26 . . . . 1.0 107.599 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -56.23 -18.79 11.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 123.494 0.496 . . . . 1.0 109.939 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.29 -51.56 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.01 0.91 . . . . 1.0 111.834 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 36.0 tp -44.66 -84.21 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.335 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -78.27 0.98 23.18 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 117.488 -1.685 . . . . 1.0 109.151 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -86.02 -28.05 24.41 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 113.933 -3.107 . . . . 1.0 109.055 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.41 -31.84 24.44 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.5 mt -75.11 -40.61 59.8 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 114.032 -1.44 . . . . 1.0 108.329 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -64.0 -33.28 75.37 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 118.733 -1.187 . . . . 1.0 108.282 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -85.18 -27.99 6.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 114.578 -2.849 . . . . 1.0 110.549 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.412 ' N ' HD12 ' A' ' 70' ' ' ILE . 6.0 t-160 -67.51 -41.06 85.03 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 115.945 -2.302 . . . . 1.0 106.107 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -73.52 -48.8 30.34 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 111.881 -2.418 . . . . 1.0 113.458 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -53.31 -39.58 64.13 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.893 -0.723 . . . . 1.0 109.968 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.11 -42.05 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 124.086 0.866 . . . . 1.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.96 43.17 2.29 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 110.258 -1.137 . . . . 1.0 110.258 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 118.828 -2.572 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -78.93 59.77 2.71 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.753 -0.832 . . . . 1.0 108.753 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 48.02 3.38 0.01 OUTLIER Glycine 0 N--CA 1.506 3.363 0 N-CA-C 116.787 1.475 . . . . 1.0 116.787 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -78.8 -2.77 41.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.414 -1.05 . . . . 1.0 108.249 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p -60.06 -39.84 87.43 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-O 125.242 2.449 . . . . 1.0 107.954 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -58.48 -19.43 36.98 Favored 'General case' 0 C--N 1.287 -2.151 1 CA-C-N 108.018 -4.174 . . . . 1.0 112.243 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.91 -32.58 73.14 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.288 -1.375 . . . . 1.0 107.288 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.84 -43.53 22.46 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 104.629 -3.388 . . . . 1.0 104.629 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' HD12 ' A' ' 60' ' ' ILE . 82.4 t -52.26 -45.87 44.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.0 mt-10 -60.27 -24.0 64.58 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 116.922 -1.911 . . . . 1.0 111.99 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.56 -14.6 62.93 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 117.769 -1.572 . . . . 1.0 109.854 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 57' ' ' VAL . 12.6 mt -90.56 -56.8 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 122.782 1.277 . . . . 1.0 108.257 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.531 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.81 -36.12 54.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 113.798 -1.547 . . . . 1.0 108.439 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -63.4 -14.46 50.53 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.538 -1.265 . . . . 1.0 112.776 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tt -131.59 3.74 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.438 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 57.7 tp -99.95 -90.15 0.32 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 104.661 -2.348 . . . . 1.0 104.661 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 13.3 pt20 -65.51 -3.87 5.08 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 116.68 -2.008 . . . . 1.0 111.948 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -80.1 -27.76 39.16 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 116.935 -1.906 . . . . 1.0 107.088 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.0 mt -86.5 -36.97 18.68 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.217 1.484 . . . . 1.0 107.316 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 99.1 mt -70.4 -39.7 74.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.924 -1.489 . . . . 1.0 110.087 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -64.98 -34.45 78.47 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.74 -26.21 6.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 114.642 -2.823 . . . . 1.0 110.752 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.462 ' N ' HD12 ' A' ' 70' ' ' ILE . 15.0 t-160 -69.56 -40.06 77.03 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 117.465 -1.694 . . . . 1.0 107.063 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -79.0 -47.68 15.82 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.711 -2.495 . . . . 1.0 115.005 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -51.16 -33.07 25.38 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.914 -0.715 . . . . 1.0 111.81 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -80.7 -19.74 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.22 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 154.67 -29.68 0.68 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.666 0 O-C-N 118.069 -3.018 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.691 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -75.55 60.7 1.24 Allowed 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.877 0.846 . . . . 1.0 111.892 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' ASP . . . -58.76 -30.32 65.76 Favored Glycine 0 N--CA 1.501 2.968 0 CA-C-N 115.303 -0.862 . . . . 1.0 114.374 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 8.0 t70 140.37 -64.66 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.56 -34.64 78.73 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 124.636 2.16 . . . . 1.0 108.507 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -60.79 -20.46 61.54 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 109.353 -3.567 . . . . 1.0 111.805 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.17 -29.67 70.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.511 -1.292 . . . . 1.0 107.511 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.52 -50.99 13.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 104.792 -3.323 . . . . 1.0 104.792 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 60' ' ' ILE . 60.8 t -47.49 -51.32 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 113.459 -1.371 . . . . 1.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.416 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 9.4 mm-40 -57.78 -25.66 60.83 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 114.295 -1.32 . . . . 1.0 112.535 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.41 -26.21 58.2 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.578 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 57' ' ' VAL . 16.0 mt -76.33 -59.11 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 114.416 -1.265 . . . . 1.0 108.467 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.7 pp -52.66 -42.01 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 114.054 -1.43 . . . . 1.0 107.99 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.494 ' N ' HD12 ' A' ' 61' ' ' ILE . 38.5 ttp180 -50.67 -29.84 12.13 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.954 -1.099 . . . . 1.0 113.198 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.44 0.24 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.404 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.9 tp -69.31 -102.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.06 -0.719 . . . . 1.0 109.06 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.479 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 3.0 pm0 -64.13 1.03 0.78 Allowed 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 117.709 -1.596 . . . . 1.0 112.322 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -37.38 85.87 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 117.836 -1.545 . . . . 1.0 107.834 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 mt -81.03 -27.51 35.77 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 123.944 1.831 . . . . 1.0 110.611 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 90.9 mt -76.5 -29.37 56.79 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 112.084 -2.325 . . . . 1.0 106.637 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.28 -41.12 83.63 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 106.549 -1.648 . . . . 1.0 106.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -91.35 -21.35 6.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 C-N-CA 113.746 -3.181 . . . . 1.0 111.616 -179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -87.46 -6.8 58.25 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.398 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -115.46 -46.61 2.86 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 107.093 -1.447 . . . . 1.0 107.093 179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -52.06 -41.53 62.42 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 119.662 -0.815 . . . . 1.0 112.098 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.6 mt -76.03 -10.21 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.832 0.825 . . . . 1.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.6 -25.49 2.84 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.417 -1.873 . . . . 1.0 108.417 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.689 0 O-C-N 119.965 -1.903 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 50' A ACE . . . . . 0.415 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . . . . . . 0 C--O 1.212 -0.901 . . . . . . . . 1.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.24 -20.32 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 118.681 2.845 . . . . 1.0 118.681 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 50' A ACE . . . -133.98 43.0 1.3 Allowed Glycine 0 N--CA 1.502 3.066 0 O-C-N 124.225 0.953 . . . . 1.0 112.689 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -142.15 -34.67 0.45 Allowed 'General case' 0 N--CA 1.503 2.198 0 CA-C-O 122.751 1.263 . . . . 1.0 109.564 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.2 t -64.31 -28.03 69.43 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 124.75 2.214 . . . . 1.0 110.066 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -60.68 -21.3 62.7 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 110.208 -3.178 . . . . 1.0 111.296 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.86 -30.91 71.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.404 -1.332 . . . . 1.0 107.404 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.66 -50.52 19.47 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 104.474 -3.451 . . . . 1.0 104.474 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' HD12 ' A' ' 60' ' ' ILE . 75.1 t -48.35 -49.17 13.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 122.106 0.955 . . . . 1.0 110.4 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HA ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -58.25 -27.19 63.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 114.514 -1.221 . . . . 1.0 112.009 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.58 60.74 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.757 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.456 HD12 ' HA ' ' A' ' 57' ' ' VAL . 9.1 mt -81.18 -53.92 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-N 113.784 -1.553 . . . . 1.0 108.791 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.549 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.08 -33.93 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 106.795 -1.557 . . . . 1.0 106.795 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmt180 -52.12 -24.33 6.78 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.8 tt -127.53 29.0 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 122.64 1.21 . . . . 1.0 108.711 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 48.8 tp -99.51 -96.79 0.24 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 113.714 -1.585 . . . . 1.0 106.759 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.502 HE21 ' NE2' ' A' ' 66' ' ' GLN . 4.0 pp0? -60.86 -0.8 0.33 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.119 1.155 . . . . 1.0 114.119 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.502 ' NE2' HE21 ' A' ' 65' ' ' GLN . 20.9 mp0 -75.36 -37.22 60.76 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.196 -1.779 . . . . 1.0 106.196 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 60.0 mt -74.02 -37.33 64.38 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 113.495 -1.684 . . . . 1.0 108.512 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 76.2 mt -74.53 -34.62 63.04 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.028 -1.896 . . . . 1.0 108.524 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.538 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 5.8 t80 -63.34 -39.42 94.5 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.036 -1.838 . . . . 1.0 106.036 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -84.48 -23.64 7.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 114.708 -2.797 . . . . 1.0 113.183 -179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.459 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.6 t-160 -85.53 -23.18 27.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 114.606 -1.179 . . . . 1.0 112.083 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.595 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.18 -40.24 6.52 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 114.468 -1.242 . . . . 1.0 112.702 -179.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.538 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -71.39 -44.95 64.0 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.356 -0.938 . . . . 1.0 109.761 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 50.6 mt -79.46 -30.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 C-N-CA 119.19 -1.004 . . . . 1.0 109.842 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.61 -85.93 0.72 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.022 -1.231 . . . . 1.0 110.022 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.804 0 O-C-N 118.229 -2.924 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.897 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 58.09 -5.02 0.05 Allowed 'General case' 0 N--CA 1.511 2.584 0 N-CA-C 116.735 2.124 . . . . 1.0 116.735 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.03 36.85 0.64 Allowed Glycine 0 N--CA 1.503 3.14 0 N-CA-C 114.617 0.607 . . . . 1.0 114.617 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.96 28.23 1.42 Allowed 'General case' 0 N--CA 1.502 2.168 0 CA-C-O 122.022 0.915 . . . . 1.0 109.369 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -63.95 -25.28 68.07 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 124.65 2.167 . . . . 1.0 109.993 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -57.6 -20.94 36.09 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 110.57 -3.014 . . . . 1.0 112.715 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.47 69.24 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.395 -1.322 . . . . 1.0 108.442 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.37 -52.08 11.43 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 104.833 -3.307 . . . . 1.0 104.833 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 84.1 t -47.57 -51.79 6.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.178 0.989 . . . . 1.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.438 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 4.1 mm-40 -57.31 -23.12 46.59 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.443 -1.253 . . . . 1.0 113.213 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.89 -18.39 50.75 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.354 -1.338 . . . . 1.0 108.955 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 mt -88.3 -50.42 13.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.156 -1.424 . . . . 1.0 107.156 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.81 -39.61 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 120.018 -0.673 . . . . 1.0 109.408 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -32.98 31.64 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.148 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 tt -116.88 22.9 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 122.123 0.963 . . . . 1.0 111.53 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 64' ' ' LEU . 46.0 tp -95.26 -114.03 0.12 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 103.602 -2.74 . . . . 1.0 103.602 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 9.2 pm0 -68.69 20.66 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 118.266 -1.373 . . . . 1.0 112.989 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -80.33 -38.28 30.9 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.462 -1.681 . . . . 1.0 106.462 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -75.74 -33.42 60.25 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 123.845 1.783 . . . . 1.0 107.055 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 95.0 mt -76.62 -36.34 57.5 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 112.534 -2.121 . . . . 1.0 108.685 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -64.91 -36.26 83.79 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -82.07 -29.66 9.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 114.885 -2.726 . . . . 1.0 110.035 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.526 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.6 t-160 -67.02 -35.52 80.09 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 117.64 -1.624 . . . . 1.0 107.546 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -79.0 -47.16 16.75 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 113.596 -1.638 . . . . 1.0 111.217 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.93 -42.32 48.16 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.825 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.3 mt -99.45 -37.83 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 123.853 0.721 . . . . 1.0 112.569 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.47 44.76 1.46 Allowed Glycine 0 N--CA 1.503 3.152 0 CA-C-O 122.129 0.849 . . . . 1.0 112.449 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.66 0 O-C-N 118.551 -2.735 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -75.44 67.08 1.94 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.804 0.811 . . . . 1.0 110.082 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.438 ' C ' ' H ' ' A' ' 53' ' ' THR . . . 63.35 29.03 73.3 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -81.77 39.41 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.549 -1.278 . . . . 1.0 107.549 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 51' ' ' GLY . 11.7 t -86.28 -21.0 27.58 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 124.36 2.029 . . . . 1.0 111.928 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -58.1 -19.75 34.61 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 111.63 -2.532 . . . . 1.0 113.129 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.23 -27.98 68.83 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 118.589 -1.244 . . . . 1.0 108.05 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.75 -49.65 22.74 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 105.673 -2.971 . . . . 1.0 105.673 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.7 t -52.55 -48.2 47.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.851 0.834 . . . . 1.0 109.472 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -56.06 -26.88 51.09 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.802 -1.159 . . . . 1.0 112.521 179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.48 62.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.419 -1.312 . . . . 1.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.38 -52.38 10.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.29 -1.323 . . . . 1.0 108.717 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -59.89 -35.7 62.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.307 -1.368 . . . . 1.0 107.307 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 mtt-85 -53.93 -15.66 1.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.753 -1.179 . . . . 1.0 112.325 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.4 -47.56 2.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 C-N-CA 119.427 -0.909 . . . . 1.0 111.206 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.0 tp -45.68 -87.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 114.511 -1.222 . . . . 1.0 111.149 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 4.9 pt20 -79.99 4.91 15.49 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 115.7 -2.4 . . . . 1.0 109.431 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.72 -35.44 57.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 116.098 -2.241 . . . . 1.0 107.832 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.65 -27.19 27.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.15 -1.42 . . . . 1.0 108.099 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 82.6 mt -76.99 -37.97 54.09 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.761 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.8 -33.63 76.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -85.01 -29.78 6.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 115.475 -2.49 . . . . 1.0 109.783 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.457 ' N ' HD12 ' A' ' 70' ' ' ILE . 5.3 t60 -66.46 -41.72 88.61 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 116.631 -2.028 . . . . 1.0 106.152 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 7.5 m-85 -71.55 -51.13 25.15 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 112.436 -2.165 . . . . 1.0 111.413 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.0 ttp85 -55.07 -39.71 69.53 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.891 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.0 mt -89.0 -13.15 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.95 -0.7 . . . . 1.0 110.399 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.42 -48.62 3.18 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.204 -1.558 . . . . 1.0 109.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.675 0 O-C-N 119.145 -2.385 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.822 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.8 t80 83.22 100.82 0.05 OUTLIER 'General case' 0 N--CA 1.51 2.558 0 O-C-N 125.334 1.646 . . . . 1.0 108.927 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 118.48 -14.51 11.89 Favored Glycine 0 N--CA 1.501 3.024 0 C-N-CA 120.437 -0.887 . . . . 1.0 112.314 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.27 -13.33 61.11 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 106.702 -1.592 . . . . 1.0 106.702 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.84 -31.27 71.51 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.957 1.837 . . . . 1.0 110.456 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -64.26 -16.98 63.15 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 110.085 -3.234 . . . . 1.0 113.218 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.07 73.09 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 117.982 -1.487 . . . . 1.0 108.593 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.84 -49.6 13.26 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 104.315 -3.514 . . . . 1.0 104.315 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HA ' HD12 ' A' ' 60' ' ' ILE . 67.0 t -48.36 -49.63 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 114.436 -0.882 . . . . 1.0 110.117 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.435 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 5.2 mm-40 -54.22 -29.35 46.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.095 -0.957 . . . . 1.0 111.523 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -29.08 64.34 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.277 -1.369 . . . . 1.0 109.512 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 57' ' ' VAL . 10.7 mt -77.61 -54.22 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 113.572 -1.649 . . . . 1.0 108.869 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.5 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.4 pp -57.16 -39.09 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.86 -31.37 17.08 Favored 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.435 -0.906 . . . . 1.0 111.379 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.36 -18.46 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 112.949 0.722 . . . . 1.0 112.949 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . 47.3 tp -57.21 -94.48 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.212 0.605 . . . . 1.0 110.672 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.515 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 9.1 pm0 -70.47 4.56 2.27 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 116.424 -2.11 . . . . 1.0 111.535 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -38.77 79.85 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 117.011 -1.875 . . . . 1.0 106.437 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.7 mt -78.34 -24.54 46.46 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 123.175 1.464 . . . . 1.0 109.944 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 78.5 mt -78.25 -28.85 47.86 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 112.948 -1.933 . . . . 1.0 106.731 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -56.88 -41.98 79.02 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.639 -1.245 . . . . 1.0 107.639 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -88.65 -22.24 6.7 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 113.467 -3.293 . . . . 1.0 111.382 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 5.4 t60 -80.17 -15.44 57.05 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 118.33 -1.348 . . . . 1.0 107.989 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -105.29 -41.38 5.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.754 179.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -52.39 -32.67 39.92 Favored 'General case' 0 N--CA 1.507 2.383 0 C-N-CA 118.842 -1.143 . . . . 1.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.1 mt -76.21 -12.97 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-O 121.886 0.851 . . . . 1.0 111.655 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.09 -44.79 0.27 Allowed Glycine 0 N--CA 1.495 2.629 0 CA-C-N 114.682 -1.145 . . . . 1.0 110.653 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.298 -1.663 0 O-C-N 118.245 -2.915 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.698 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 46.3 m-85 71.49 -63.2 0.43 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-O 123.419 1.581 . . . . 1.0 112.593 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.29 -78.19 0.01 OUTLIER Glycine 0 N--CA 1.492 2.376 0 CA-C-N 110.22 -3.173 . . . . 1.0 109.675 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 26.7 t70 -172.18 16.27 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 114.396 -0.902 . . . . 1.0 110.974 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.1 t -68.14 -20.79 64.93 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.349 -1.34 . . . . 1.0 110.914 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -63.42 -19.62 64.85 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 111.48 -2.6 . . . . 1.0 111.652 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.72 -1.192 . . . . 1.0 107.881 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.08 -27.64 61.86 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.399 -1.88 . . . . 1.0 108.399 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.2 t -74.53 -54.84 13.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 113.892 -1.154 . . . . 1.0 108.245 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 4.4 mt-10 -55.82 -22.56 25.4 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.197 -1.401 . . . . 1.0 111.666 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.08 -28.68 69.78 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 123.104 1.43 . . . . 1.0 108.6 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 18.5 mt -72.83 -55.58 12.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 ' HA ' ' HB3' ' A' ' 64' ' ' LEU . 1.8 mp -50.25 -47.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-O 123.454 1.597 . . . . 1.0 108.669 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' GLU . 64.6 ttt180 -50.22 -25.91 4.14 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 110.079 -3.237 . . . . 1.0 112.076 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.44 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.5 mp -111.49 -30.26 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.621 1.201 . . . . 1.0 109.144 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 65' ' ' GLN . 4.4 tt -48.69 -65.75 0.51 Allowed 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 126.36 1.864 . . . . 1.0 111.181 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' N ' HD23 ' A' ' 64' ' ' LEU . 3.6 pt20 -84.01 -5.63 59.26 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 117.39 -1.724 . . . . 1.0 109.73 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 63' ' ' ILE . 1.4 mp0 -83.19 -28.37 29.36 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 116.791 -1.964 . . . . 1.0 107.794 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 3.9 pp -90.35 -33.64 16.0 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 60.2 mt -74.93 -38.87 61.67 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.646 -1.222 . . . . 1.0 109.529 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.83 -38.07 84.2 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 117.819 -1.552 . . . . 1.0 107.086 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.7 pp -83.54 -24.6 7.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 114.871 -2.732 . . . . 1.0 113.445 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.418 ' N ' HD12 ' A' ' 70' ' ' ILE . 23.7 t-160 -79.44 -24.66 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 118.547 -1.261 . . . . 1.0 108.642 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -93.05 -52.12 4.73 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.926 -1.488 . . . . 1.0 111.108 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -48.73 -41.64 32.67 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.261 1.578 . . . . 1.0 115.261 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 41.0 mt -80.55 -12.75 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 C-N-CA 120.036 -0.666 . . . . 1.0 112.327 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 135.96 54.38 0.06 OUTLIER Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.013 -1.635 . . . . 1.0 109.013 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.293 -1.849 0 O-C-N 119.22 -2.341 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.74 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -75.45 56.83 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 120.427 -0.509 . . . . 1.0 112.226 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 53' ' ' THR . . . 156.73 31.71 0.02 OUTLIER Glycine 0 N--CA 1.503 3.135 0 C-N-CA 119.274 -1.441 . . . . 1.0 115.945 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -83.81 27.24 0.65 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-O 122.516 1.151 . . . . 1.0 109.218 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 51' ' ' GLY . 0.8 OUTLIER -60.14 -25.25 65.34 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 124.243 1.973 . . . . 1.0 110.109 -179.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -60.62 -21.96 63.28 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 110.271 -3.15 . . . . 1.0 112.802 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.39 70.58 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 118.487 -1.285 . . . . 1.0 108.42 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.64 12.66 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 104.796 -3.321 . . . . 1.0 104.796 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.88 -49.84 14.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 114.15 -1.025 . . . . 1.0 110.532 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.7 mt-10 -60.96 -21.52 63.55 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.401 -1.72 . . . . 1.0 113.153 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.98 -23.12 58.23 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 117.996 -1.481 . . . . 1.0 108.153 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mt -82.03 -57.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 113.496 -1.684 . . . . 1.0 107.792 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -56.05 -38.81 54.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.118 -1.033 . . . . 1.0 110.785 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.33 -28.13 57.97 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.039 -1.064 . . . . 1.0 111.009 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.1 tt -114.86 21.7 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.488 1.137 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 30.9 tp -94.73 -99.18 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.347 -1.752 . . . . 1.0 106.651 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 19.8 pt20 -65.67 0.02 1.88 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 117.399 -1.72 . . . . 1.0 114.009 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 61' ' ' ILE . 1.3 mp0 -69.08 -36.92 78.12 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 116.647 -2.021 . . . . 1.0 108.04 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.6 pp -86.48 -23.22 26.04 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 118.36 -1.336 . . . . 1.0 110.51 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 61.6 mt -78.52 -27.24 46.03 Favored 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -57.81 -42.94 85.29 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 106.798 -1.556 . . . . 1.0 106.798 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -90.42 -20.56 6.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 113.782 -3.167 . . . . 1.0 111.839 -179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 68' ' ' LEU . 8.0 t60 -84.75 -9.94 57.71 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.197 -1.401 . . . . 1.0 108.687 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.563 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.4 OUTLIER -109.96 -48.4 3.21 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 107.32 -1.363 . . . . 1.0 107.32 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -46.08 -35.27 4.78 Favored 'General case' 0 N--CA 1.51 2.531 0 N-CA-C 114.548 1.314 . . . . 1.0 114.548 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.94 -19.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 113.077 0.769 . . . . 1.0 113.077 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.86 -37.51 4.67 Favored Glycine 0 N--CA 1.504 3.174 0 CA-C-O 122.201 0.89 . . . . 1.0 112.369 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.727 0 O-C-N 119.009 -2.465 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.889 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 49.38 23.27 0.83 Allowed 'General case' 0 N--CA 1.506 2.362 0 N-CA-C 116.621 2.082 . . . . 1.0 116.621 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.31 15.53 39.31 Favored Glycine 0 N--CA 1.505 3.264 0 C-N-CA 120.109 -1.044 . . . . 1.0 111.935 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -109.89 39.41 2.14 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.02 0.438 . . . . 1.0 112.044 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 19.7 p -81.49 -38.68 25.95 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 124.549 2.119 . . . . 1.0 113.401 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -49.37 -19.7 0.56 Allowed 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 109.836 -3.347 . . . . 1.0 115.635 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.6 -32.67 74.42 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.592 -1.243 . . . . 1.0 108.526 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.57 -53.21 21.7 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 105.251 -3.14 . . . . 1.0 105.251 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' HD12 ' A' ' 60' ' ' ILE . 57.1 t -48.46 -50.08 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 114.128 -1.036 . . . . 1.0 111.086 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -59.32 -27.3 65.77 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 116.517 -2.073 . . . . 1.0 112.425 -179.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.51 -17.45 64.67 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 117.942 -1.503 . . . . 1.0 110.287 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.423 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.6 mt -90.01 -52.44 10.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.083 -1.417 . . . . 1.0 107.98 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -60.26 -35.36 61.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 C-N-CA 118.245 -1.382 . . . . 1.0 108.142 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 12.1 mmt85 -50.53 -24.39 3.17 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 123.796 0.685 . . . . 1.0 111.677 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 tt -119.75 -39.74 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.64 -1.224 . . . . 1.0 112.432 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.7 tp -55.73 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.965 -1.016 . . . . 1.0 111.784 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -74.12 -5.64 42.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 115.943 -2.303 . . . . 1.0 108.522 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.24 -27.66 35.12 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 115.984 -2.286 . . . . 1.0 109.502 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 68' ' ' LEU . 4.4 pp -89.25 -28.42 19.93 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 117.208 -1.797 . . . . 1.0 106.392 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 81.3 mt -77.41 -40.03 44.98 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.623 -1.172 . . . . 1.0 109.549 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.465 ' HB3' ' O ' ' A' ' 65' ' ' GLN . 2.1 t80 -65.01 -32.96 74.95 Favored 'General case' 0 CA--C 1.483 -1.622 0 N-CA-C 107.966 -1.124 . . . . 1.0 107.966 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.09 -29.16 7.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 114.621 -2.831 . . . . 1.0 110.581 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.432 ' N ' HD12 ' A' ' 70' ' ' ILE . 10.1 t-160 -68.79 -39.89 79.93 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 116.17 -2.212 . . . . 1.0 107.437 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.0 m-85 -76.26 -47.84 22.39 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 111.681 -2.509 . . . . 1.0 113.752 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -57.39 -40.14 77.57 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 119.345 -0.942 . . . . 1.0 109.975 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 59.3 mt -78.07 -42.86 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.223 -0.991 . . . . 1.0 109.401 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 103.39 47.5 1.3 Allowed Glycine 0 N--CA 1.5 2.96 0 CA-C-O 122.558 1.088 . . . . 1.0 111.076 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.696 0 O-C-N 118.632 -2.687 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.731 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -78.57 65.78 3.93 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.277 1.037 . . . . 1.0 108.733 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -165.35 38.89 0.28 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 108.373 -1.891 . . . . 1.0 108.373 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -125.77 26.12 6.73 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 114.37 -0.915 . . . . 1.0 111.3 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.2 t -89.26 -32.51 17.36 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 124.187 1.946 . . . . 1.0 113.306 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -56.91 -21.89 33.27 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 111.284 -2.689 . . . . 1.0 113.575 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.9 -31.88 73.07 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.63 -1.248 . . . . 1.0 107.63 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.96 -47.9 22.86 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 104.45 -3.46 . . . . 1.0 104.45 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HA ' HD12 ' A' ' 60' ' ' ILE . 98.5 t -49.88 -48.65 22.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.648 -0.776 . . . . 1.0 111.141 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 3.2 mt-10 -60.93 -22.92 64.87 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 117.882 -1.527 . . . . 1.0 112.988 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -72.39 -17.61 61.8 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.393 -1.323 . . . . 1.0 108.637 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 57' ' ' VAL . 15.3 mt -87.44 -59.05 2.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 113.677 -1.601 . . . . 1.0 106.934 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -54.83 -38.63 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 119.779 -0.768 . . . . 1.0 109.771 -179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -57.63 -24.31 55.83 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.519 -0.873 . . . . 1.0 112.273 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 tt -125.89 -4.13 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 C-N-CA 118.927 -1.109 . . . . 1.0 112.672 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 25.4 tp -85.56 -95.37 0.08 Allowed 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 105.398 -2.075 . . . . 1.0 105.398 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.24 4.51 1.25 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 117.712 -1.595 . . . . 1.0 111.525 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -84.04 -32.46 24.85 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 116.713 -1.995 . . . . 1.0 106.283 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.23 -37.51 57.61 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.629 -1.619 . . . . 1.0 106.629 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 79.9 mt -73.59 -38.24 65.2 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.537 -1.665 . . . . 1.0 107.464 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 73' ' ' ARG . 9.6 t80 -58.64 -41.6 86.39 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 105.974 -1.862 . . . . 1.0 105.974 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.99 -20.42 8.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 C-N-CA 113.953 -3.099 . . . . 1.0 113.984 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -89.35 -13.92 36.78 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.302 -0.959 . . . . 1.0 109.798 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.565 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -113.39 -49.89 2.88 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.844 -1.071 . . . . 1.0 112.971 -179.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -62.38 -23.24 66.7 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 117.936 -1.506 . . . . 1.0 111.752 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.0 mt -88.02 -9.33 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.842 -0.743 . . . . 1.0 109.032 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.42 -37.39 1.75 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.392 -1.083 . . . . 1.0 110.392 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.773 0 O-C-N 119.561 -2.14 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.705 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -73.36 10.56 0.98 Allowed 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.865 -0.734 . . . . 1.0 112.831 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -20.66 -79.94 0.01 OUTLIER Glycine 0 N--CA 1.501 2.984 0 N-CA-C 116.948 1.539 . . . . 1.0 116.948 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -168.94 -10.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 N-CA-C 114.509 1.3 . . . . 1.0 114.509 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.5 p -58.52 -29.25 66.15 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 124.801 2.239 . . . . 1.0 109.237 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -57.41 -23.35 48.91 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 109.026 -3.715 . . . . 1.0 112.43 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.67 72.42 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.269 -1.382 . . . . 1.0 107.269 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.4 -50.59 15.46 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 103.662 -3.775 . . . . 1.0 103.662 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' HA ' HD12 ' A' ' 60' ' ' ILE . 95.8 t -46.67 -52.21 3.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 114.802 -0.699 . . . . 1.0 110.834 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.426 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -57.06 -26.15 59.87 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 113.216 0.821 . . . . 1.0 113.216 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.5 -23.45 61.8 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 118.346 -1.342 . . . . 1.0 109.452 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 57' ' ' VAL . 7.4 mt -83.08 -51.15 14.85 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 113.834 -1.53 . . . . 1.0 108.83 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -62.85 -35.58 71.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 118.964 -1.094 . . . . 1.0 108.14 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.2 mtt180 -56.51 -21.75 28.18 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.048 -1.061 . . . . 1.0 111.917 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 tt -116.09 -39.6 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.306 -1.358 . . . . 1.0 111.621 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 55.5 tp -58.64 -80.58 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.062 0.934 . . . . 1.0 110.411 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.45 -4.8 24.41 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 116.637 -2.025 . . . . 1.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.03 -25.64 21.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 116.048 -2.261 . . . . 1.0 109.309 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 64' ' ' LEU . 4.1 pp -84.48 -27.58 27.37 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 72' ' ' PHE . 92.6 mt -77.03 -38.08 53.55 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 113.692 -1.595 . . . . 1.0 108.429 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.43 -36.81 84.98 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.969 -1.092 . . . . 1.0 108.516 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.9 pp -81.52 -29.98 10.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 114.781 -2.768 . . . . 1.0 109.92 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.493 ' N ' HD12 ' A' ' 70' ' ' ILE . 8.6 t-160 -76.28 -27.12 56.52 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 115.847 -2.341 . . . . 1.0 109.139 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 2.5 m-85 -85.31 -44.71 12.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.036 -0.984 . . . . 1.0 110.244 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -56.91 -40.34 76.11 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.213 -1.403 . . . . 1.0 107.213 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 37.1 mt -90.63 -37.33 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 113.536 0.939 . . . . 1.0 113.536 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.83 13.38 57.75 Favored Glycine 0 N--CA 1.503 3.103 0 CA-C-O 121.818 0.677 . . . . 1.0 113.298 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.823 0 O-C-N 118.092 -3.005 . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' A ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.823 . . . . . . . . 1.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 70.66 -45.88 0.61 Allowed 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.322 1.601 . . . . 1.0 115.322 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -20.21 -57.03 0.01 OUTLIER Glycine 0 N--CA 1.505 3.261 0 CA-C-N 112.941 -1.936 . . . . 1.0 115.408 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -126.27 29.52 5.79 Favored 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 112.779 0.659 . . . . 1.0 112.779 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.2 t -81.42 -17.43 48.92 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-O 122.788 1.28 . . . . 1.0 111.222 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -59.53 -21.91 60.92 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 112.075 -2.329 . . . . 1.0 112.278 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.45 -29.37 67.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.946 -1.131 . . . . 1.0 107.946 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.91 -54.44 11.91 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 105.356 -3.098 . . . . 1.0 105.356 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.0 t -49.2 -49.31 17.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 CA-C-O 121.614 0.721 . . . . 1.0 110.987 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' CG1' ' A' ' 61' ' ' ILE . 0.6 OUTLIER -61.64 -24.23 66.58 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 117.153 -1.819 . . . . 1.0 112.899 -179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.7 -21.31 63.5 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.443 -1.703 . . . . 1.0 108.514 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -82.17 -57.96 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 113.943 -1.481 . . . . 1.0 108.387 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.523 ' C ' HD12 ' A' ' 61' ' ' ILE . 1.5 pp -57.22 -34.4 45.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.285 -0.966 . . . . 1.0 109.137 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -54.3 -25.22 22.5 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 123.673 0.608 . . . . 1.0 110.809 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 6.1 tt -119.96 -38.42 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 115.105 1.52 . . . . 1.0 115.105 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.3 tp -43.43 -75.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.499 1.12 . . . . 1.0 110.274 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.483 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 10.7 pt20 -74.81 -2.3 26.03 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 116.833 -1.947 . . . . 1.0 109.655 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -73.81 -34.99 64.83 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 105.57 -2.011 . . . . 1.0 105.57 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 63' ' ' ILE . 89.2 mt -78.11 -32.93 50.77 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 113.704 -1.589 . . . . 1.0 108.221 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 65' ' ' GLN . 73.2 mt -73.69 -35.88 65.21 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.468 -1.242 . . . . 1.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -65.83 -35.17 79.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.369 -1.345 . . . . 1.0 107.369 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 71' ' ' HIS . 2.8 pp -84.48 -29.08 6.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 115.313 -2.555 . . . . 1.0 109.308 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.452 ' N ' HD12 ' A' ' 70' ' ' ILE . 13.7 t-160 -65.1 -40.74 94.97 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 117.994 -1.482 . . . . 1.0 107.006 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 3.0 m-85 -78.58 -48.17 15.72 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 112.507 -2.133 . . . . 1.0 112.681 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.217 -0.993 . . . . 1.0 110.707 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 33.2 mt -89.26 -36.12 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.11 -74.34 0.26 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 120.213 -0.994 . . . . 1.0 111.262 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.793 0 O-C-N 118.131 -2.982 . . . . 1.0 . . . . . . . . . . 0 0 . 1 stop_ save_